After returning from injury, he will enter the Red Devils vision? 21-year-old Belgian iron waist Lavia may become Manchester United s "bottom-buying" sign in the winter window

Marchist - The smoke of the transfer window has just dispersed, and Manchester United has quietly arranged troops for the next battle. According to the exclusive news of Miguel Delaney, the chief follower of the Independent, Chelsea midfielder Romeo Lavia has entered the Red Devils' winter window to sign radar, becoming Casemiro's long-term stand-in.

"Engine" is in a hurry, Amorin bets on both sides

at the beginning of the season, Manchester United's midfield barrier is in a hurry: Casemiro's physical fitness is red light, Manuel Ugat dives in form, Ruben Amorin has to let Bruno Fernandez retreat and form a double midfielder with the Brazilian. The coaching staff knew that this was just a stopgap measure. They asked Brighton for Carlos Baleba this summer, but returned home because of the price of Seagulls of up to £70 million. Now, Lavia has suddenly jumped to the focus of Plan B with the label of "low price and high potential".

Diamond data under the shadow of injury

After landing at Stamford Bridge for 62 million euros in the summer window of 2023, Lavia missed the last 70 games due to multiple injuries such as hamstrings and ankles. Blues fans have long been "scared of" at him. But the data will not lie: According to Fbref statistics, the Belgian's pass success rate ranks 96% of the same position in Europe, and the dribbling surpasses the 92% of the rating; in the absence of the ball, the average interception average is also at the 92% of the rating. Manchester City's youth training production also gives him natural Premier League adaptability.

Winter Window Game: Buy at the bottom or take another bet?

Compared with Baleba, which is still rising prices, Lavia's trading valuation has shrunk significantly due to injury history. If Manchester United takes action, it is expected to complete the interception at a "fragmented price". However, the medical team will play a key role - any relapse of an old injury may instantly devalue the deal. Now, Inios' management is assessing the two-line: Should we continue to pursue the battle power of Baleba, or should we bet on Ravia's talent and health?

Amorin's record pressure has been written on his face, and every decision in the winter window may determine the direction of Manchester United's season. Is Ravia the next "injury Zhongyong" or the future answer to the Red Devils midfielder? The answer may be revealed in 90 days.